ClinConnect ClinConnect Logo
Search / Trial NCT06892158

Massage Impact on Sleep in Pediatric Oncology

Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Mar 18, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Stem Cell Transplant (Sct) Decreased Sleep Efficiency Pediatric Cancer Diagnosis Circadian Activity Rhythm (Car)

ClinConnect Summary

This clinical trial is studying the effects of massage therapy on sleep for young patients with cancer, specifically those undergoing intensive treatments like chemotherapy or stem cell transplants. Researchers want to find out if massage can help improve sleep quality in these children and teenagers, who often face challenges with sleep during their treatment.

To participate in this study, young people aged 12 to 21 who are being treated for conditions like acute myeloid leukemia or are receiving stem cell transplants are eligible. They need to be staying at the hospital for at least 21 days. Participants will receive massage therapy during their treatment, and the study will look at how this affects their sleep. It's important to note that those with certain cognitive impairments or language barriers may not be able to participate. Overall, this trial aims to provide insight into how a simple therapy like massage can support the well-being of young cancer patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Diagnosis of cancer, such as acute myeloid leukemia (AML) or relapsed acute lymphoblastic leukemia (rALL) OR admitted to receive autologous or allogeneic HSCT for any indication
  • 2. Expected to be an inpatient for at least 21 days
  • 3. Aged 12 to 21 years at enrollment.
  • 4. Inpatient at Children's National or Children's Hospital of Philadelphia (CHOP).
  • Exclusion Criteria:
  • 1. Cognitive impairment sufficient to preclude completing questionnaires appropriately
  • 2. Insufficient knowledge of English or Spanish that would prohibit completing the study instruments
  • 3. Previous enrollment

About Children's Hospital Of Philadelphia

The Children's Hospital of Philadelphia (CHOP) is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and clinical care. As a prominent clinical trial sponsor, CHOP emphasizes a multidisciplinary approach to pediatric research, fostering collaborations across various specialties to develop and evaluate groundbreaking therapies and interventions. With a focus on improving patient outcomes and enhancing the quality of life for children, CHOP is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and scientific integrity, ultimately contributing to the global knowledge base in pediatric medicine.

Locations

Philadelphia, Pennsylvania, United States

Washington, District Of Columbia, United States

Patients applied

0 patients applied

Trial Officials

Tracey Jubelirer, MD

Principal Investigator

Children's Hospital of Philadelphia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported